Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Truncated azinomycin analogues intercalate into DNA

Maxwell A Casely-Hayford1, Klaus Pors, Laurence H Patterson

  • 1Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX, UK.

Bioorganic & Medicinal Chemistry Letters
|January 25, 2005
PubMed
Summary

Researchers designed a new azinomycin analogue, compound 4, for improved therapeutic potential. This compound, like natural azinomycin 3, binds to DNA and causes unwinding, indicating a similar mechanism of action.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA damaging properties of G-quadruplex ligand QN-302 are potentiated by the DNA repair inhibitor Olaparib and mitigated by the molecular helicase PhpC.

Genome biology·2026
Same author

RNA functional modulation by Mitoxantrone via RNA structural ensemble repartitioning.

Nature communications·2026
Same author

Innovative Nanocarriers of Sorafenib in the Optimisation of Therapeutic Outcome: Challenges and Applications in Breast Cancer.

AAPS PharmSciTech·2026
Same author

Comprehensive proteome profiling of cytochrome P450 isoforms in cancer models.

Clinical proteomics·2025
Same author

Cancer stem cells in focus: Deciphering the dynamic functional landscape of stemness in cancer.

Biochimica et biophysica acta. Reviews on cancer·2025
Same author

Cellular adaptations impact the biological activity of naphthalene diimide G-quadruplex ligands in ALT-positive osteosarcoma cells.

Cell death & disease·2025

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Azinomycin is a natural product with DNA-binding properties.
  • Developing analogues with enhanced therapeutic viability is crucial for drug development.

Purpose of the Study:

  • To design and synthesize a novel azinomycin analogue with potentially improved therapeutic efficacy.
  • To investigate the DNA-binding properties and mechanism of action of the synthesized analogue.

Main Methods:

  • Chemical synthesis involving the coupling of a piperidine mustard to the azinomycin chromophore.
  • DNA-binding assays to assess the interaction between the analogue and DNA.
  • DNA unwinding studies to elucidate the mode of binding.

Main Results:

Related Experiment Videos

  • A novel azinomycin analogue, compound 4, was successfully designed and synthesized.
  • Both compound 4 and the natural azinomycin 3 demonstrated DNA binding.
  • Evidence of DNA unwinding was observed for both compounds, suggesting an intercalative binding mode.

Conclusions:

  • The synthesized azinomycin analogue 4 shows promise as a potential therapeutic agent.
  • The analogue shares the DNA-binding and unwinding properties of the natural product, supporting an intercalative mechanism.
  • Further research into analogue 4 could lead to new chemotherapeutic strategies.